Nicorandil reduced coronary events in stable angina
- Effects of allopurinol upon exercise in patients with angina. Kuritzky, Louis // Internal Medicine Alert;8/15/2010 Supplement 3, p119
The article presents a study on the effects of allopurinol on exercising angina patients.
- Epidural morphine for outpatients with severe anginal pain. Clemensen, Soren Eigil; Thayssen, Per; Hole, Peter // British Medical Journal (Clinical Research Edition);2/21/1987, Vol. 294 Issue 6570, p475
Investigates the effectivity of morphine in the management of severe anginal pain in outpatients. Implantation of an epidural system of analgesia subcutaneously; Doses of morphine administered; Success of the drug in angina intervention.
- Try subcutaneous heparin for patients with unstable angina. // Modern Medicine;Oct95, Vol. 63 Issue 10, p40
Presents an abstract of the article `Randomised Comparison of Subcutaneous Heparin, Intravenous Heparin, and Aspirin in Unstable Angina,' by G.G. Neri Serneri, P.A. Modesti, G.F. Gensini, et al from `The Lancet' dated May 13, 1995.
- AN AMINE OXIDASE INHIBITOR IN ANGINA. Halprin, Harry // Angiology;Aug1960, Vol. 11 Issue 4, p348
1. A new amine oxidase regulator, Marplan, in daily doses of from 15 to 40 mg, was given to 15 patients with angina pectoris and 2 with symptoms associated with neurocirculatory disorders over periods of from 1 to 6 months. 2. Significant relief of pain was reported by 14 of the 17 patients...
- Ranexa. // Formulary;Mar2006, Vol. 41 Issue 3, p108
The article talks about ranolazine as an anti-anginal agent for patients not responsive to other therapies. It was approved on January 27, 2006, for the treatment of chronic angina. The efficacy of ranolazine was evaluated in patients with chronic angina who remained symptomatic despite...
- Efficacy and Tolerability of Nisoldipine Coat-Core vs Diltiazem Retard in Combination with a Beta-Blocker in Patients with Stable Exertional Angina Pectoris. Melcher, A.; Abelin, J.; Luurila, O. // Clinical Drug Investigation;1998, Vol. 15 Issue 5, p389
A randomised, double-blind, placebo-controlled, parallel-group trial with forced titration study to investigate possible equivalence of efficacy and tolerability between nisoldipine coat-core (CC) 40mg once daily, and diltiazem retard 120mg twice daily, was carried out in 176 patients with...
- Blockers and verapamil: a cautionary tale. Hutchison, S.J.; Lorimer, A.R.; Lakhdar, A.; McAlpine, S.G. // British Medical Journal (Clinical Research Edition);9/15/1984, Vol. 289 Issue 6446, p659
Examines the treatment of angina pectoris with beta adrenoceptor blocking agents and verapamil. Efficacy of beta adrenoceptor and verapamil; Prohibition on the drug intake intravenously; Prevention on the development of an iatrogenic.
- Effect of New Beta-Adrenergic Blocking Agent, Atenolol (Tenormin), on Pain Frequency, Trinitrin Consumption, and Exercise Ability. Roy, P.; Day, L.; Sowton, E. // British Medical Journal;7/26/1975, Vol. 3 Issue 5977, p195
Studies the effects of Atenolol on pain frequency, trinitrin consumption and exercise ability on patients with established angina pectoris. Discussion on beta-blocking drugs; Advantages of Atenolol in patients developing cardiac failure; Recommended dosage of the drug.
- Angina: the treatment revolution. // British Medical Journal;11/10/1979, Vol. 2 Issue 6199, p1167
Examines the effectiveness of beta-adrenergic blocking drugs in the treatment of angina pectoris. Effects of an organic obstruction within the major coronary arteries; Development of effective drugs and surgical treatments for angina pectoris; Use of coronary angiography to find out if a...